COMMUNIQUÉS West-GlobeNewswire

OSE Immunotherapeutics to Implement a Flexible Bridge Equity Financing
28/05/2026
First step of a global financing strategy, as the Company is actively engaging with institutional investors in the United States and in Europe Gross proceeds could amount to €19.3 million based on current share price 1 [...]
OSE Immunotherapeutics met en place un financement relais flexible en fonds propres
28/05/2026
Première étape d’une stratégie globale de financement ; la Société a intensifié ses interactions avec les investisseurs institutionnels aux Etats-Unis et en Europe Le produit brut pourrait représenter 19,3 millions d’ [...]
Sequana Medical announces results of Annual General Meeting of Shareholders
28/05/2026
Ghent, Belgium, May 28, 2026 (GLOBE NEWSWIRE) -- PRESS RELEASE | REGULATED INFORMATION | 28 May 2026, 9:00 pm CEST Ghent, Belgium – 28 May 2026 – Sequana Medical NV (Euronext Brussels: SEQUA) (the " Company " or " [...]
Aclarion, Inc. Comments on Echo Lake Capital’s Letter and Unsolicited Proposal
28/05/2026
BROOMFIELD, Colo., May 28, 2026 (GLOBE NEWSWIRE) -- Aclarion, Inc ., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented [...]
Guidepoint Qsight Launches Medical Aesthetics Patient Journey Analytics Product
28/05/2026
New York, NY, USA, May 28, 2026 (GLOBE NEWSWIRE) -- New Dashboard Provides Data-Driven Insights on Treatment Pairings and Cross-Purchasing Over Time Analyzes rates of cross-purchasing between medical aesthetic [...]
Hospital Bed Solutions by Prosperity Health Releases Industry Report on Rising Aging-in-Place Demand Across New England
28/05/2026
As more seniors choose to age in place, Hospital Bed Solutions, a Prosperity Health brand, says hospital beds, mobility equipment, and respiratory support are becoming essential tools for home-based care. Boston, MA, [...]
Bay Area Lyme Foundation Raises $900,000 at LymeAid 2026, Presenting Inaugural Neil L. Spector, MD, Legacy Award and $300,000 in Emerging Leader Grants
28/05/2026
Dana Carvey Emceed; Chris Isaak Performed at Annual Gala Advancing Lyme and Tick-Borne Disease Research PORTOLA VALLEY, Calif., May 28, 2026 (GLOBE NEWSWIRE) -- Bay Area Lyme Foundation , the nation's leading public [...]
Medx Holdings (MEDH) Announces Landmark Submission for DEA Registration Through Lazydaze ABQ LLC, Joining an Elite Group of Public Companies Pioneering Federal Medical Cannabis Access
28/05/2026
Medx Holdings Submits DEA Registration in a Major Push to Normalize the Medical Cannabis Lifestyle Austin, Texas, May 28, 2026 (GLOBE NEWSWIRE) -- FOR IMMEDIATE RELEASE Medx Holdings Announces Landmark Submission for [...]
Tevogen Advances Strategic Acquisition Initiatives with Potential to Support Approximately $100 Million in Combined Annual Revenue
28/05/2026
WARREN, N.J., May 28, 2026 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN ) today announced continued progress across its strategic acquisition initiatives intended to complement [...]
New research reveals COVID-19's long-term impact on kids
28/05/2026
Washington, DC, May 28, 2026 (GLOBE NEWSWIRE) -- New research from Children’s National Hospital and the National Institutes of Health (NIH) is offering one of the most comprehensive insights yet into how COVID-19 [...]
Valneva to Participate at U.S. and European Investor Conferences in June
28/05/2026
Lyon (France), May 28, 2026 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that its senior management will present and hold investor meetings at several upcoming investor [...]
Valneva annonce sa participation à des conférences investisseurs aux États-Unis et en Europe
28/05/2026
Lyon (France), le 28 mai 2026 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), société spécialisée dans les vaccins, a annoncé aujourd’hui que des membres de son équipe dirigeante participeront, en juin 2026, à [...]
Clue Becomes the First Insurance-Covered Period and Menstrual Cycle Tracker in the World
28/05/2026
BERLIN, May 28, 2026 (GLOBE NEWSWIRE) -- Clue , the #1 women-led period and cycle tracker, today announced a partnership with Süddeutsche Krankenversicherung a. G. (SDK), one of Germany’s leading private health insurers [...]
H1 Receives $40M Investment in Round Led by CVS Health Ventures
28/05/2026
H1 helps healthcare players transform operations with AI NEW YORK, May 28, 2026 (GLOBE NEWSWIRE) -- H1 recently received a $40M investment in a round led by CVS Health Ventures , the venture capital investment platform [...]
Pemvidutide Demonstrates Significant Metabolic Improvements in Patients with MASH in New 48‑Week IMPACT Phase 2b Data Presented at EASL 2026
28/05/2026
“Best of EASL” oral presentation highlights meaningful reductions in triglycerides, cholesterol, and blood pressure, along with improvements in key metabolic risk factors PERFORMA Phase 3 trial to further evaluate the [...]
RadioMedix to Present at SNMMI 2026 and Mark 20 Years of Radiopharmaceutical Innovation
28/05/2026
Company’s SNMMI week activities highlight scientific progress and two decades of advancing precision nuclear medicine for patients with hard-to-treat cancers HOUSTON, May 28, 2026 (GLOBE NEWSWIRE) -- RadioMedix, Inc., a [...]
Pharming Group announces results of 2026 Annual General Meeting of Shareholders
28/05/2026
Leiden, the Netherlands, May 28, 2026: Pharming Group (“Pharming” or “the Company”) (Euronext Amsterdam: PHARM / Nasdaq: PHAR) today announced that shareholders approved all proposals presented at its Annual General [...]
Fortis Life Sciences Expands AbNano® Portfolio with First VHH Library Derived from Peripheral Natural Killer Cells for Rapid Antibody Discovery
28/05/2026
The new AbNano® library enables VHH discovery against complex NK-cell-associated targets for engineered cell platforms and translational research BOSTON, May 28, 2026 (GLOBE NEWSWIRE) -- Fortis Life Sciences today [...]
ProMIS Neurosciences to Participate in Upcoming Conferences in June
28/05/2026
CAMBRIDGE, Mass., May 28, 2026 (GLOBE NEWSWIRE) -- ProMIS Neurosciences Inc. (Nasdaq: PMN), a clinical-stage biotechnology company developing antibody therapeutics and vaccines targeting toxic misfolded proteins in [...]

Pages